PubMed

Immunology of cardiovascular disease.

Virella G.

Clin Immunol. 2009 Jun 15. [Epub ahead of print] No abstract available. PMID: 19535296 [PubMed - as supplied by publisher]Related articles

Clinical significance of the humoral immune response to modified LDL.

Lopes-Virella MF, Virella G.

Clin Immunol. 2009 May 7. [Epub ahead of print]PMID: 19427818 [PubMed - as supplied by publisher]Related articles

Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.

Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G; Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group.

Diabetes Care. 2008 Oct;31(10):2006-12. Epub 2008 Jul 15.PMID: 18628568 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.

Hammad SM, Twal WO, Barth JL, Smith KJ, Saad AF, Virella G, Argraves WS, Lopes-Virella MF.

Atherosclerosis. 2009 Feb;202(2):394-404. Epub 2008 May 28.PMID: 18597759 [PubMed - indexed for MEDLINE]Related articles

Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.

Virella G, Carter RE, Saad A, Crosswell EG, Game BA; DCCT/EDIC Study Group, Lopes-Virella MF.

Clin Immunol. 2008 Jun;127(3):394-400.PMID: 18533284 [PubMed - indexed for MEDLINE]Related articlesFree article

Atherogenesis and the humoral immune response to modified lipoproteins.

Virella G, Lopes-Virella MF.

Atherosclerosis. 2008 Oct;200(2):239-46. Epub 2008 Apr 12. Review.PMID: 18513726 [PubMed - indexed for MEDLINE]Related articlesFree article

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF.

J Lipid Res. 2006 Sep;47(9):1975-83. Epub 2006 Jun 27.PMID: 16804192 [PubMed - indexed for MEDLINE]Related articlesFree article

Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.

Lopes-Virella MF, McHenry MB, Lipsitz S, Yim E, Wilson PF, Lackland DT, Lyons T, Jenkins AJ, Virella G; DCCT/EDIC Research Group.

Atherosclerosis. 2007 Feb;190(2):359-69. Epub 2006 Mar 10.PMID: 16530770 [PubMed - indexed for MEDLINE]Related articles

Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.

Yishak AA, Costacou T, Virella G, Zgibor J, Fried L, Walsh M, Evans RW, Lopes-Virella M, Kagan VE, Otvos J, Orchard TJ.

Nephrol Dial Transplant. 2006 Jan;21(1):93-100. Epub 2005 Sep 6.PMID: 16144851 [PubMed - indexed for MEDLINE]Related articlesFree article

The immunogenicity of modified lipoproteins.

Lopes-Virella MF, Thorpe SR, Derrick MB, Chassereau C, Virella G.

Ann N Y Acad Sci. 2005 Jun;1043:367-78. Review.PMID: 16037258 [PubMed - indexed for MEDLINE]Related articles

Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

Costacou T, Lopes-Virella MF, Zgibor JC, Virella G, Otvos J, Walsh M, Orchard TJ.

J Diabetes Complications. 2005 Jul-Aug;19(4):183-93.PMID: 15993351 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.

Cassidy WM, Jones G, Williams K, Deforest A, Forghani B, Virella G, Venters C.

J Adolesc Health. 2005 Mar;36(3):187-92.PMID: 15737773 [PubMed - indexed for MEDLINE]Related articles

Development of capture assays for different modifications of human low-density lipoprotein.

Virella G, Derrick MB, Pate V, Chassereau C, Thorpe SR, Lopes-Virella MF.

Clin Diagn Lab Immunol. 2005 Jan;12(1):68-75.PMID: 15642987 [PubMed - indexed for MEDLINE]Related articlesFree article

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.

Virella G, Thorpe SR, Alderson NL, Derrick MB, Chassereau C, Rhett JM, Lopes-Virella MF.

J Lipid Res. 2004 Oct;45(10):1859-67. Epub 2004 Jul 16.PMID: 15258197 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of simvastatin as an immunomodulator in type 2 diabetes.

Lopes-Virella MF, Mironova M, Stephan E, Durazo-Arvizu R, Virella G.

Diabetes Care. 2004 Apr;27(4):908-13.PMID: 15047647 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.

Lopes-Virella MF, Virella G.

Front Biosci. 2003 Sep 1;8:s750-68. Review.PMID: 12957881 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein autoantibodies: measurement and significance.

Virella G, Lopes-Virella MF.

Clin Diagn Lab Immunol. 2003 Jul;10(4):499-505. Review. No abstract available. PMID: 12853376 [PubMed - indexed for MEDLINE]Related articlesFree article

LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-1.

Fu Y, Huang Y, Bandyopadhyay S, Virella G, Lopes-Virella MF.

J Lipid Res. 2003 Jul;44(7):1315-21. Epub 2003 May 1.PMID: 12730303 [PubMed - indexed for MEDLINE]Related articlesFree article

Humoral immunity and atherosclerosis.

Virella G, Lopes-Virella MF.

Nat Med. 2003 Mar;9(3):243-4; author reply 244-5. No abstract available. PMID: 12612552 [PubMed - indexed for MEDLINE]Related articles

Autoimmune response to advanced glycosylation end-products of human LDL.

Virella G, Thorpe SR, Alderson NL, Stephan EM, Atchley D, Wagner F, Lopes-Virella MF; DCCT/EDIC Research Group.

J Lipid Res. 2003 Mar;44(3):487-93. Epub 2002 Dec 1.PMID: 12562876 [PubMed - indexed for MEDLINE]Related articlesFree article

Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

Virella G, Atchley D, Koskinen S, Zheng D, Lopes-Virella MF; DCCT/EDIC Research Group.

Clin Immunol. 2002 Oct;105(1):81-92.PMID: 12483997 [PubMed - indexed for MEDLINE]Related articles

Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.

Atchley DH, Lopes-Virella MF, Zheng D, Kenny D, Virella G.

Diabetologia. 2002 Nov;45(11):1562-71. Epub 2002 Oct 12.PMID: 12436340 [PubMed - indexed for MEDLINE]Related articles

Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII).

Vielma S, Virella G, Gorod A, Lopes-Virella M.

Clin Immunol. 2002 Sep;104(3):265-73.PMID: 12217337 [PubMed - indexed for MEDLINE]Related articles

Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia.

Hall PD, Virella G, Willoughby T, Atchley DH, Kreitman RJ, Frankel AE.

Clin Immunol. 2001 Aug;100(2):191-7.PMID: 11465948 [PubMed - indexed for MEDLINE]Related articles

Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.

Huang Y, Fleming AJ, Wu S, Virella G, Lopes-Virella MF.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2533-8.PMID: 11116049 [PubMed - indexed for MEDLINE]Related articlesFree article

The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.

Lopes-Virella MF, Koskinen S, Mironova M, Horne D, Klein R, Chassereau C, Enockson C, Virella G.

Atherosclerosis. 2000 Sep;152(1):107-15.PMID: 10996345 [PubMed - indexed for MEDLINE]Related articles

Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.

Mironova MA, Klein RL, Virella GT, Lopes-Virella MF.

Diabetes. 2000 Jun;49(6):1033-41.PMID: 10866057 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.

Virella G, Koskinen S, Krings G, Onorato JM, Thorpe SR, Lopes-Virella M.

Clin Immunol. 2000 May;95(2):135-44.PMID: 10779407 [PubMed - indexed for MEDLINE]Related articles

Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.

Orchard TJ, Virella G, Forrest KY, Evans RW, Becker DJ, Lopes-Virella MF.

Diabetes. 1999 Jul;48(7):1454-8.PMID: 10389853 [PubMed - indexed for MEDLINE]Related articlesFree article

Ehrlichiosis with severe pulmonary manifestations despite early treatment.

Weaver RA, Virella G, Weaver A.

South Med J. 1999 Mar;92(3):336-9.PMID: 10094281 [PubMed - indexed for MEDLINE]Related articles

Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.

Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY.

Clin Immunol. 1999 Feb;90(2):165-72.PMID: 10080827 [PubMed - indexed for MEDLINE]Related articles

Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.

Koskinen S, Enockson C, Lopes-Virella MF, Virella G.

Clin Diagn Lab Immunol. 1998 Nov;5(6):817-22.PMID: 9801341 [PubMed - indexed for MEDLINE]Related articlesFree article

Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation.

Rogers RL, Javed TA, Ross RE, Virella G, Stuart RK, Frei-Lahr D.

Am J Hematol. 1998 Apr;57(4):326-30.PMID: 9544978 [PubMed - indexed for MEDLINE]Related articles

The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.

Lopes-Virella MF, Binzafar N, Rackley S, Takei A, La Via M, Virella G.

Atherosclerosis. 1997 Dec;135(2):161-70.PMID: 9430365 [PubMed - indexed for MEDLINE]Related articles

Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.

Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF.

Clin Immunol Immunopathol. 1997 Oct;85(1):73-82.PMID: 9325072 [PubMed - indexed for MEDLINE]Related articles

Stress-induced immunosuppression and therapeutic touch.

Olson M, Sneed N, LaVia M, Virella G, Bonadonna R, Michel Y.

Altern Ther Health Med. 1997 Mar;3(2):68-74.PMID: 9061991 [PubMed - indexed for MEDLINE]Related articles

Long-term exercise patterns and immune function in healthy older women. A report of preliminary findings.

Gueldner SH, Poon LW, La Via M, Virella G, Michel Y, Bramlett MH, Noble CA, Paulling E.

Mech Ageing Dev. 1997 Feb;93(1-3):215-22.PMID: 9089585 [PubMed - indexed for MEDLINE]Related articles

Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.

Lopes-Virella MF, Virella G.

Ann Med. 1996 Aug;28(4):347-54. Review.PMID: 8862690 [PubMed - indexed for MEDLINE]Related articles

Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.

Lopes-Virella MF, Virella G.

Diabetes. 1996 Jul;45 Suppl 3:S40-4. Review.PMID: 8674888 [PubMed - indexed for MEDLINE]Related articles

Modification of lipoproteins in diabetes.

Lopes-Virella MF, Klein RL, Virella G.

Diabetes Metab Rev. 1996 Apr;12(1):69-90. Review. No abstract available. PMID: 8861502 [PubMed - indexed for MEDLINE]Related articles

Isolation and characterization of human antioxidized LDL autoantibodies.

Mironova M, Virella G, Lopes-Virella MF.

Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):222-9. Erratum in: Arterioscler Thromb Vasc Biol 1997 Oct;17(10):2306. PMID: 8620336 [PubMed - indexed for MEDLINE]Related articlesFree article

Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.

Virella G, Muñoz JF, Galbraith GM, Gissinger C, Chassereau C, Lopes-Virella MF.

Clin Immunol Immunopathol. 1995 May;75(2):179-89.PMID: 7704977 [PubMed - indexed for MEDLINE]Related articles

A population-based serologic survey of immunity to tetanus in the United States.

Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G.

N Engl J Med. 1995 Mar 23;332(12):761-6.PMID: 7862178 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparing assays of antibodies to modified low-density lipoproteins.

Virella G, Mironova M, Lopes-Virella MF.

Clin Chem. 1995 Feb;41(2):324-5. No abstract available. PMID: 7874792 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunological function in post-traumatic splenosis.

Hathaway JM, Harley RA, Self S, Schiffman G, Virella G.

Clin Immunol Immunopathol. 1995 Feb;74(2):143-50.PMID: 7828368 [PubMed - indexed for MEDLINE]Related articles

Atherosclerosis and autoimmunity.

Lopes-Virella MF, Virella G.

Clin Immunol Immunopathol. 1994 Nov;73(2):155-67. Review.PMID: 7923923 [PubMed - indexed for MEDLINE]Related articles

Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.

Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF.

Int J Clin Lab Res. 1993;23(2):95-101.PMID: 8518420 [PubMed - indexed for MEDLINE]Related articles

Biosynthesis, metabolism and biological properties of immunoglobulins.

Virella G, Wang AC.

Immunol Ser. 1993;58:91-102. Review. No abstract available. PMID: 8424996 [PubMed - indexed for MEDLINE]Related articles

Tissues and cells involved in the immune response.

Virella G, Patrick C, Goust JM.

Immunol Ser. 1993;58:9-27. Review. No abstract available. PMID: 8424995 [PubMed - indexed for MEDLINE]Related articles

Immunoglobulin structure.

Virella G, Wang AC.

Immunol Ser. 1993;58:75-90. Review. No abstract available. PMID: 8424994 [PubMed - indexed for MEDLINE]Related articles